Not sure if someone has already mention this but if Sofdra (sofpironium) is typically reimbursed under Medicare Part D or private insurance, not Part B.
Would Big Pharma look at the potential of huge losses in revenue and be looking aggressively for drugs like Sofdra to buy to fill the gap??
Maybe a silver lining?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.010(3.33%) |
Mkt cap ! $568.6M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 29.0¢ | $1.517M | 5.072M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 1133673 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 161846 | 3 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |